Showing results (1231-1240 of 6,326) with videos related to

Sort By:
Pageof 633
Diabetes, Obesity & Metabolism|June 20, 2024
A review of the latest real-world evidence studies in diabetic kidney disease: What have we learned about clinical practice and the clinical effectiveness of interventions?Fabrice Bonnet, Mark E Cooper, Laetitia Kopp, et al.
Diabetes, Obesity & Metabolism|June 19, 2024
Association of KLF14 rs4731702 gene polymorphism with metabolic phenotype in young patients with type 1 diabetesMonika Ryba-Stanisławowska, Bartosz Słomiński, Małgorzata Myśliwiec
Diabetes, Obesity & Metabolism|June 19, 2024
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trialKathryn Cardoza, Amy Kang, Brendan Smyth, et al.
Diabetes, Obesity & Metabolism|November 5, 2023
Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post-hoc analysis of the ROTATE-3 studyTom T G F Lieverse, Maria J Puchades, Udo D J Mulder, et al.
Diabetes, Obesity & Metabolism|November 5, 2023
Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetesJarl Hellman, Niels Vaever Hartvig, Anne Kaas, et al.
Diabetes, Obesity & Metabolism|November 6, 2023
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysisEmily R Hankosky, Hui Wang, Lisa M Neff, et al.
Diabetes, Obesity & Metabolism|November 20, 2023
Improvement of early-phase insulin secretion is an independent factor for achieving glycaemic control: A pooled analysis of SEED and DAWN studyLingge Feng, Chunxiang Chen, Quanle Guo, et al.
Diabetes, Obesity & Metabolism|October 23, 2023
Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta-analysisAlvin Kuate Defo, Veselko Bakula, Alessandro Pisaturo, et al.
Diabetes, Obesity & Metabolism|October 23, 2023
Ultra-rapid lispro improved postprandial glucose control compared to insulin lispro in predominantly Chinese patients with type 1 diabetes: A prospective, randomized, double-blind phase 3 studyJianhua Ma, Xiang Yan, Qiong Feng, et al.
Diabetes, Obesity & Metabolism|October 23, 2023
Repeated detection of non-alcoholic fatty liver disease increases the incidence risk of type 2 diabetes in young adultsJin Hwa Kim, Young Sang Lyu, Mee Kyoung Kim, et al.
Pageof 633